# Godrej Agrovet share price today (Godrej Agrovet Ltd, NSE: GODREJAGRO)

> Godrej Agrovet share price today: ₹595.20 at the NSE close on 4 November 2026, up 1.0% in a year. Godrej Agrovet (NSE: GODREJAGRO) is worth ₹11,456 crore, trades at a P/E of 24.4 and has closed between ₹513.00 and ₹675.85 over the past 52 weeks. > Godrej Agrovet Ltd's P/E is near the low end of its own history, higher than only 13% of past readings, and its quarterly results are still getting worse. GODREJAGRO · FMCG - Animal/Polutry · data as of 4 November 2026. Page: https://www.sectoralpha.in/stocks/godrej-agrovet-ltd

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Mixed, from fewer quarters than usual
- Price: ₹595.20 (+1.0% in a year)
- P/E: 24.4× (lower than 87% of the last 9 years)
- Revenue (Jun 2026): ₹2,855 Cr (+9.2% on a year ago)
- Profit (Jun 2026): ₹128 Cr (−14.1% on a year ago)
- Operating margin: 8.0% (−2.0 points on a year ago)
- ROCE: 19%, FY26
- Profit that came in as cash: 243%, last 3 years

The main question: the P/E is near the low end of its own history, higher than only 13% of past readings, but results are getting worse. A low multiple can stay low until the quarters turn. ## What is the Godrej Agrovet share price today? Godrej Agrovet Ltd's share price was ₹595.20 at the close on 4 November 2026. It has been rising for 6 weeks. That is 2.5% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹513 and ₹676, and at that close it sat 50% of the way up from that low. Over the past 13 weeks it has done better than the NIFTY 500, and it has stayed ahead for 12 weeks in a row. Over the last 9 years the share price moved +0% while the NIFTY 500 moved +142%, so it is behind the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at Godrej Agrovet this quarter? Three changes stood out: revenue up on a year earlier for 5 quarters in a row, foreign funds (FIIs) raised their stake for 3 quarters in a row and highest quarterly revenue in 15 quarters. 1. Revenue up on a year earlier for 5 quarters in a row In the June 2026 quarter revenue was ₹2,855 crore, +9.2% on a year earlier. Why: Revenue rose because Animal Nutrition and Oil Palm led the quarter. From the earnings call on 6 Aug 2026. 2. Foreign funds (FIIs) raised their stake for 3 quarters in a row From 6.3% to 6.6% of the company by the September 2026 quarter. 3. Highest quarterly revenue in 15 quarters Revenue of ₹2,855 crore in the June 2026 quarter is the highest of the last 15 quarters. Why: The June quarter was the highest because Animal Nutrition and Oil Palm led the quarter. From the earnings call on 6 Aug 2026. ## What are Godrej Agrovet's latest quarterly results? For April to June 2026 (the quarter ended 30 June 2026), Godrej Agrovet reported revenue of ₹2,855 crore, up 9.2% from ₹2,614 crore a year earlier, and a profit of ₹128 crore, down 14.1% from ₹149 crore. ### Godrej Agrovet results: April to June 2026 against a year earlier

| Measure | April to June 2026 | April to June 2025 | Change |
| --- | --- | --- | --- |
| Revenue | ₹2,855 crore | ₹2,614 crore | +9.2% |
| Profit | ₹128 crore | ₹149 crore | −14.1% |
| Earnings per share | ₹6.99 | ₹8.35 | −16.3% |
| Operating margin | 8.0% | 10.0% | −2.0 points |

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). Godrej Agrovet's management discussed these results on a call held on 6 August 2026; what it said is further down this page. (From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.)

## What is the Godrej Agrovet share price history? Godrej Agrovet closed at ₹595.20 on 4 November 2026, up 1.0% from ₹589.55 a year earlier (7 November 2025) and down 0.4% over five years. Its highest weekly close since October 2017 was ₹839.10 on 25 July 2025. ### Godrej Agrovet share price: then and now

| When | Close | Change to 4 Nov 2026 |
| --- | --- | --- |
| 1 week ago · 30 Oct 2026 | ₹553.20 | +7.6% |
| 1 month ago · 1 Oct 2026 | ₹631.90 | −5.8% |
| 6 months ago · 8 May 2026 | ₹591.20 | +0.7% |
| 1 year ago · 7 Nov 2025 | ₹589.55 | +1.0% |
| 3 years ago · 3 Nov 2023 | ₹472.35 | +26.0% |
| 5 years ago · 4 Nov 2021 | ₹597.40 | −0.4% |
| Earliest weekly close in our records · 19 Oct 2017 | ₹592.60 | +0.4% |
| Highest weekly close since October 2017 · 25 Jul 2025 | ₹839.10 | −29.1% |
| Lowest weekly close since October 2017 · 20 Mar 2020 | ₹312.70 | +90.3% |
| 52-week high (weekly close) · 11 Sep 2026 | ₹675.85 | −11.9% |
| 52-week low (weekly close) · 23 Jan 2026 | ₹513.00 | +16.0% |

Weekly closing prices. Each change is the move from that price to the 4 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (480 weekly closes from 19 October 2017 to 4 November 2026.)

## What is the latest news on Godrej Agrovet? 4 Nov 2026: Godrej Agrovet closed at ₹595.20, up 7.6% on the week and down 5.8% on the month. 6 Aug 2026: Godrej Agrovet held its results call for April to June 2026. Management guided: FY27 consolidated profit before tax growth planned in double digits, with its position within that range reassessed by end Q2 after the Crop Care read. ### Earlier

- 29 Jul 2026: ex-date for a dividend of ₹11 a share. - Results for April to June 2026: Revenue up 9.2% and profit down 14.1% on a year earlier. ## What dividend does Godrej Agrovet pay? Godrej Agrovet paid ₹11 a share in regular dividends in the 12 months to 5 November 2026 (1 payment), a yield of 1.85% at the ₹595.20 close on 4 November 2026. The last was a dividend of ₹11 a share, ex-date 29 July 2026. ### Godrej Agrovet dividends since 1 April 2021

| Ex-date | Dividend per share | Type |
| --- | --- | --- |
| 29 Jul 2026 | ₹11 | Dividend |
| 31 Jul 2025 | ₹11 | Dividend |
| 26 Jul 2024 | ₹10 | Dividend |
| 28 Jul 2023 | ₹9.50 | Dividend |
| 22 Jul 2022 | ₹9.50 | Dividend |
| 4 Aug 2021 | ₹8 | Dividend |

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. The record date is the same day as the ex-date for every payment here. 5 of 5 Of the last 5 financial years, years with an NSE dividend record

Yes. Godrej Agrovet Ltd paid out 45% of its profit as dividends in FY26, and it paid a dividend in each of its last 13 reported years. (From the NSE corporate-actions record, read 5 November 2026.)

## What did Godrej Agrovet management say on the latest results call? On the call for April to June 2026, held on 6 August 2026, Godrej Agrovet's management guided: FY27 consolidated profit before tax growth planned in double digits, with its position within that range reassessed by end Q2 after the Crop Care read. > “Broadly, nothing crosses our threshold unless we are generating an IRR of approximately 16-18%, and this meets that threshold for us.”
> Sunil Kataria, CEO & MD, on the call for April to June 2026

### What management guided

- Oil Palm FFB volume growth high single-digit to early double-digit over 4-5 years; approximately 17,000 hectares added this year and long-range area moving from roughly 80,000 to 150,000 hectares. - FY27 Oil Palm capital spending ₹300-350 crore includes the integrated complex and specialty fats, phased over 3-4 quarters. - Astec FY27 revenue growth at least above 20%, with CDMO salience around 50-52% as customer production shifts into H2. - Crop Care operating margin maintained around 26-27%, with a clearer full-year recovery view by end Q2. Management’s own plans and goals, from our notes of the call. A plan is not a result. Source: [the call transcript](https://files.tijorifinance.com/insight/india/6070/Conference Call/CC-Aug26.pdf). (From the call for April to June 2026, 6 August 2026.)

## What to watch in Godrej Agrovet's next results? When Godrej Agrovet reports July to September 2026, these are the 4 checks that show whether the story is still on course. First: Crop Care recovery in the next print - check cotton herbicide season and diversification against the pending full-year assessment. - What to check (from the call)
- Crop Care recovery in the next print - check cotton herbicide season and diversification against the pending full-year assessment. - Astec second-half customer production shifts - check revenue conversion and enterprise margin normalization after first-quarter raw-material benefits. - Oil Palm peak-season margin recovery and specialty fats ramp - check formula pressure offset by efficiency and downstream contribution. - Dairy milk-cost pressure and route-to-market pilot - check progress toward profitable value-added growth. ## Which stock lists is Godrej Agrovet on? Godrej Agrovet is on 2 of our India lists: Breakout stocks and Dividend stocks. - [Breakout stocks Breakout date: 9 October 2026](https://www.sectoralpha.in/breakout-stocks-india)
- [Dividend stocks Regular dividend yield (%): 1.85](https://www.sectoralpha.in/dividend-stocks-india)

## Is Godrej Agrovet profitable? Godrej Agrovet Ltd earned ₹128 Cr of net profit in the Jun 2026 quarter, −14.1% on the same quarter a year earlier. Full-year FY26 profit was ₹445 Cr. Over 10 years profit has grown 5.5% a year on average. That is 4.5% of the quarter's revenue. The same quarter a year earlier earned ₹149 Cr. For the full year, FY26 profit was ₹445 Cr (+10.4% on the year before). Why profit moved: revenue changed +9.2% on a year earlier and the margin moved −2.0 percentage points. Sales did the work while the margin got thinner. On average over the last four quarters, profit changed +7.0% and revenue +8.6%. Profit and revenue are moving at about the same pace. ## How much revenue does Godrej Agrovet make, and is it growing? Godrej Agrovet Ltd reported ₹2,855 Cr of revenue in the Jun 2026 quarter, +9.2% on the same quarter a year earlier. That is the 5th quarter in a row with growth on the year before. Over 10 years it has grown 10.6% a year on average. The last full year, FY26, came in at ₹10,233 Cr. The last four reported quarters add to ₹10,473 Cr. FY26 revenue was ₹10,233 Cr, +9.1% on the year before. Recent pace: the last four quarters grew +8.6% on average, against 10.6% a year over the longer run, so this year is growing slower than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +8.6%, against +5.5% a year over the last 8 quarters (accelerating); profit over the last 12 months grew +0.7%, against +5.1% a year (rolling over). ## How much of every ₹100 of sales does Godrej Agrovet keep? Godrej Agrovet Ltd's operating margin was 8.0% in the Jun 2026 quarter, 2.0 percentage points lower than the same quarter a year ago. Across 13 years it has been between 4.6% and 9.0%. The latest quarter is within that range. Why the margin moved: operating margin changed −1.9 percentage points on the year while gross margin changed −2.7 points. So the drop came mostly from the gross margin, which means input costs and prices charged. ## Is Godrej Agrovet's profit turning into cash? Over the last 3 years, 243% of Godrej Agrovet Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹1,281 Cr of operating cash against ₹445 Cr of profit. After ₹257 Cr of spending on assets, ₹1,024 Cr was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why 243% of profit came in as cash: the cash cycle got 58 days shorter between FY21 and FY26, so cash that used to wait in the business now arrives sooner. What to look at next: no single use of cash stands out. The next section checks both the cash tied up in daily operations and the spending on assets. ## Where does Godrej Agrovet's cash go? Godrej Agrovet Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 10 days in FY26, down from 68 days in FY21. It spent ₹901 Cr on assets over the last 3 years. Customers take 24 days to pay, and stock sits for 65 days on average. At FY26 sales of ₹10,233 Cr, each day of that cycle ties up about ₹28.0 Cr, so roughly ₹280 Cr is tied up in the business at any time. FY26: customers took 24 days to pay and stock sat for 65 days, about 2.1 months of sales sitting as stock, for a full cycle of 10 days, shorter than FY21's 68. The full loop: cash goes out to suppliers and production on day 0. Stock sits for 65 days. Customers pay about 24 days after that. Suppliers are paid at 80 days. Together that makes the 10-day cycle. Spending on assets: ₹901 Cr over the last 3 years, against ₹669 Cr of depreciation (the yearly wear and tear on existing assets). So it is building a little beyond replacing what wears out. Work still in progress is ₹201 Cr (FY26): assets paid for that are not earning yet. In short: neither the daily cycle nor new spending is soaking up the cash, so the picture is fairly clean. ## What is Godrej Agrovet's P/E ratio, and how does it compare with its own history? Godrej Agrovet Ltd's P/E is 24.4×, near the low end of its own history: it has been lower only 13% of the time. Its usual P/E (the middle reading) is 31.0×, over 9 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. The P/E here, and its history, use a profit figure that can leave out one-off items, so it can differ from a P/E worked out on the quarterly results. Those results' earnings per share for the four quarters to Jun 2026 add up to ₹23.22. Why the multiple is where it is: over the past year earnings per share moved +10.0% while the price moved +1.0%. Earnings did better than the price, which pulled the multiple down within its own range. Where the price move came from: over 5 years the price moved −0.1% a year; about +7.1% a year came from earnings growth and about −7.2 percentage points from the multiple (the market paying less). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is low against its own past, so the earnings trend underneath matters more than the multiple. The PEG ratio and its quarterly curve, which only the second data source has, are not shown on this page: its two data sources disagree by up to 33% on reported income across 15 comparable periods. When two sources disagree on a figure, we leave it out on purpose. The gap is a choice, not missing data. ## Is the Godrej Agrovet business getting better or worse? Godrej Agrovet Ltd's business is giving mixed signals. There is no clear direction across the growth lines, with ROCE rising at 19.0%; each line tells part of the story. This is based on 8 quarters of 4 measures, with some gaps. Why it matters: when the lines disagree, each line above matters more than any single label. The return figures here are yearly, not quarterly. They show level and direction only; they can support the growth lines but never decide the reading alone. This reading has some gaps: at least one line is short, or the return line is not the quarterly series, so treat it with a little more caution. ## How much does Godrej Agrovet earn on its capital? Godrej Agrovet Ltd earned a ROCE of 19% in FY26. That is up from a low of 10% in FY23. We cannot compare its return on capital used with its cost of capital from the data we have. It comes from a 4.3% net margin and 1.66× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 4.3% net margin × 1.66× asset turnover × 3.03× leverage (assets divided by equity) ≈ 21.6% on equity. The margin does its share; borrowing is a big part of it. The quarterly return lines and the return-on-capital-used (ROIC) line, which only the second data source has, are not shown on this page: its two data sources disagree by up to 33% on reported income across 15 comparable periods. When two sources disagree on a figure, we leave it out on purpose. The gap is a choice, not missing data. ## Does Godrej Agrovet have too much debt? Godrej Agrovet Ltd had ₹1,574 Cr of borrowings against ₹2,032 Cr of equity in FY26, so its debt is 0.77× its equity. Its operating profit is 6 times its interest bill. Over 5 years borrowings went from ₹1,007 Cr to ₹1,574 Cr. Over the last 3 of those years it spent ₹901 Cr on assets. Part of the spending on assets is being paid for with borrowed money. The total-debt and debt-to-equity series, which only the second data source has, are not shown on this page: its two data sources disagree by up to 33% on reported income across 15 comparable periods. When two sources disagree on a figure, we leave it out on purpose. The gap is a choice, not missing data. ## What is the Godrej Agrovet shareholding pattern? Promoters cut their stake in Godrej Agrovet Ltd by 6.3 percentage points over 8 quarters, the biggest change among its owners. Promoters now own 67.7% of the company. Foreign institutions moved −0.9 points over the same period, to 6.6%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Promoters: −6.3 points over 8 quarters, to 67.7%; Foreign institutions: −0.9 points over 8 quarters, to 6.6%; Domestic institutions: −0.3 points over 8 quarters, to 5.6%. Why the owners changed: promoters drove it (−6.3 points), together with foreign institutions (−0.9 points). They reduced their stake. ## How far is Godrej Agrovet from balance-sheet trouble? For Godrej Agrovet Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does Godrej Agrovet rank in its industry? 47.9 out of 100, rank 4 of 5 in FMCG - Animal/Polutry, with 78% of the evidence available. Godrej Agrovet Ltd scores 47.9 out of 100 against the 5 companies it is compared with in FMCG - Animal/Polutry, ranking 4. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 13.1 + 15.2 + 10.7 + 8.9 = 47.9. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Godrej Agrovet compared with? Godrej Agrovet ranks 4 of 5 FMCG - Animal/Polutry companies on the 4-Factor Sector Score, with 47.9 out of 100. 1. [HMA Agro Industries Ltd](https://www.sectoralpha.in/stocks/hma-agro-industries-ltd) HMAAGRO · breaking out · Most evidence points up · 78% evidence 68.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 26.4/35 · Revenue 42.5% · Profit 100% · Operating margin change -0.1 points · 83% evidence Capital efficiency 11.0/25 · ROCE 16.2% · Operating margin 0.4% · 76% evidence Valuation 15.0/20 · P/E 5.8× · PEG n/a · 50% evidence Relative strength 16.2/20 · Lead over its industry 1.7% · Lead over NIFTY 500 4.9% · 1 year -20.9% · 100% evidence · 7 of 12 weeks ahead Exact sum: 26.4 + 11 + 15 + 16.2 = 68.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 2. [Venkys (India) Ltd](https://www.sectoralpha.in/stocks/venkys-indialtd) VENKEYS · breaking out · Evidence leans up · 96% evidence 62.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 27.2/35 · Revenue 18.3% · Profit 100% · Operating margin change 3.3 points · 88% evidence Capital efficiency 7.2/25 · ROCE 11.9% · Operating margin 6% · 100% evidence Valuation 12.5/20 · P/E 12.2× · PEG 1.68 · 100% evidence Relative strength 15.5/20 · Lead over its industry 3.5% · Lead over NIFTY 500 6.5% · 1 year -0.5% · 100% evidence · 9 of 12 weeks ahead Exact sum: 27.2 + 7.2 + 12.5 + 15.5 = 62.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [SKM Egg Products Export (India) Ltd](https://www.sectoralpha.in/stocks/skm-egg-products-export-indialtd) SKMEGGPROD · quiet · Evidence leans up · 93% evidence 62.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 24.6/35 · Revenue 21.4% · Profit 90.9% · Operating margin change -3 points · 100% evidence Capital efficiency 21.0/25 · ROCE 30.7% · Operating margin 16% · 100% evidence Valuation 15.7/20 · P/E 9.8× · PEG 0.71 · 65% evidence Relative strength 1.0/20 · Lead over its industry -6.6% · Lead over NIFTY 500 -4.2% · 1 year -7.3% · 100% evidence · 3 of 12 weeks ahead Exact sum: 24.6 + 21 + 15.7 + 1 = 62.3 · What this means: Earnings are strong; relative strength in its sector is -6.6% and the one-year return is -7.3%. 4. Godrej Agrovet Ltd this page GODREJAGRO · breaking out · Evidence leans down · 78% evidence 47.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 13.1/35 · Revenue 8.6% · Profit 0.7% · Operating margin change -2 points · 83% evidence Capital efficiency 15.2/25 · ROCE 19.2% · Operating margin 8% · 76% evidence Valuation 10.7/20 · P/E 22.7× · PEG n/a · 50% evidence Relative strength 8.9/20 · Lead over its industry -4.1% · Lead over NIFTY 500 -1.2% · 1 year -16.6% · 100% evidence · 9 of 12 weeks ahead Exact sum: 13.1 + 15.2 + 10.7 + 8.9 = 47.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [KSE Ltd](https://www.sectoralpha.in/stocks/kse-ltd) KSE · quiet · Most evidence points down · 64% evidence 34.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 3.0/35 · Revenue 5.1% · Profit -58.4% · Operating margin change -12 points · 88% evidence Capital efficiency 14.4/25 · ROCE 33.6% · Operating margin -0.1% · 100% evidence Valuation 9.6/20 · P/E 12.2× · PEG n/a · 15% evidence Relative strength 7.5/20 · Lead over its industry n/a · Lead over NIFTY 500 -9.3% · 1 year -32.5% · 25% evidence · 0 of 12 weeks ahead Exact sum: 3 + 14.4 + 9.6 + 7.5 = 34.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [FMCG - Animal/Polutry](https://www.sectoralpha.in/sectors/fmcg-animal-polutry), all 5 compared on one page. ## Which companies are close to Godrej Agrovet in size? Godrej Agrovet is the largest of 5 FMCG - Animal/Polutry companies on Sector Alpha by market value (scores of 30 October 2026). It is the largest. Just below it: Venkys (India), HMA Agro Industries, SKM Egg Products Export (India) and KSE. ### FMCG - Animal/Polutry companies close in size

1. Godrej Agrovet Ltd ₹10,644 crore
2. [Venkys (India) Ltd](https://www.sectoralpha.in/stocks/venkys-indialtd) ₹2,119 crore
3. [HMA Agro Industries Ltd](https://www.sectoralpha.in/stocks/hma-agro-industries-ltd) ₹1,245 crore
4. [SKM Egg Products Export (India) Ltd](https://www.sectoralpha.in/stocks/skm-egg-products-export-indialtd) ₹1,018 crore
5. [KSE Ltd](https://www.sectoralpha.in/stocks/kse-ltd) ₹561 crore

[All 5 FMCG - Animal/Polutry companies, largest first](https://www.sectoralpha.in/sectors/fmcg-animal-polutry#all-companies)

### Companies close in size in other industries

1. [EID Parry (India) Ltd](https://www.sectoralpha.in/stocks/eid-parry-indialtd) ₹10,685 crore · Sugar
2. [Cartrade Tech Ltd](https://www.sectoralpha.in/stocks/cartrade-tech-ltd) ₹10,646 crore · Platform - Others
3. Godrej Agrovet Ltd ₹10,644 crore
4. [Saregama India Ltd](https://www.sectoralpha.in/stocks/saregama-india-ltd) ₹10,578 crore · Music Licensing
5. [Voltamp Transformers Ltd](https://www.sectoralpha.in/stocks/voltamp-transformers-ltd) ₹10,472 crore · Capital Goods - Transformers

## What else do people ask about Godrej Agrovet? ### What is Godrej Agrovet's share price today? Godrej Agrovet Ltd's share price is ₹595.20, +1.0% over the past year. The whole company is worth ₹11,456 Cr on the market. In the last 52 weeks it traded between ₹513 to ₹676; today it is 50% of the way up from the low, 2.5% below its 200-day average (as of 4 November 2026). ### What were Godrej Agrovet's latest quarterly results? Godrej Agrovet Ltd reported revenue of ₹2,855 Cr and net profit of ₹128 Cr for the Jun 2026 quarter. Revenue rose 9.2% and profit fell 14.1% compared with a year earlier. Earnings per share were ₹6.99. The operating margin was 8.0%, 2.0 percentage points lower than a year earlier (as of 4 November 2026). ### What is Godrej Agrovet's market cap? Godrej Agrovet Ltd's market capitalisation is ₹11,456 Cr at a share price of ₹595.20. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 4 November 2026). ### How is Godrej Agrovet performing? Godrej Agrovet Ltd's share price has been rising for 6 weeks. In its latest quarter, revenue rose 9.2% and profit fell 14.1% compared with a year earlier. Over the past 13 weeks it has done better than the NIFTY 500, for 12 weeks running (as of 4 November 2026). ### Will Godrej Agrovet's share price go up? This page does not forecast Godrej Agrovet Ltd's share price. What it shows instead: the share price is ₹595.20, and it has been rising for 6 weeks. Its P/E of 24.4× is higher than 13% of its own last 9 years (as of 4 November 2026). ### Who owns Godrej Agrovet? Promoters own 67.7% of Godrej Agrovet Ltd, foreign institutions 6.6%, domestic institutions 5.6% and the public 20.1% (latest quarter). The biggest change over the last two years: Promoters cut their stake by 6.3 percentage points over 8 quarters (as of 4 November 2026). ### Where is Godrej Agrovet in its business cycle? Godrej Agrovet Ltd's FY26 operating margin was 8.0%, against a 13-year range of 4.6% to 9.0%: the middle of its own range, neither a peak nor a low. The latest quarter was 8.0%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 4 November 2026). ### What could break the Godrej Agrovet story? The main question: the P/E is near the low end of its own history, higher than only 13% of past readings, but results are getting worse. A low multiple can stay low until the quarters turn. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 4 November 2026). ### Is Godrej Agrovet a stock worth studying right now? What the numbers show: Godrej Agrovet Ltd's P/E is near the low end of its own history, higher than only 13% of past readings, and its quarterly results are still getting worse. The main open question: whether results start to improve. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 4 November 2026). ### Is there a Godrej Agrovet share price forecast for 2026? What management itself guided: FY27 consolidated profit before tax growth planned in double digits, with its position within that range reassessed by end Q2 after the Crop Care read. ## Lists

- Breakout stocks: https://www.sectoralpha.in/breakout-stocks-india
- Dividend stocks: https://www.sectoralpha.in/dividend-stocks-india

This is research, not advice. We’re not SEBI-registered.